A vaccine for strep A is on the horizon after scientists spotted antibodies that fight the infection
A vaccine for strep A is on the horizon after scientists spotted antibodies that fight the infection
A vaccine that protects against step A could be on the horizon after scientists made a breakthrough in understanding how the body fights bacteria.
Strep A it usually causes a mild infection, such as strep throat, impetigo, and scarlet fever. But in extremely rare cases it can lead to a fatal disease. He has killed 24 children in the UK in recent months.
As it stands, the infection can be easily treated with antibiotics if caught early. However, if the bacteria were to become drug-resistant, it would pose a ‘major threat to public health’, experts say.
But Swedish scientists have now found an antibody that fights Strep A bacteria in an unusual way, which they believe could be key to developing a vaccine.

Swedish scientists have now found an antibody that fights Strep A bacteria in an unusual way, which they believe could be key to vaccine development

Strep A is a bacteria that can cause throat, skin and respiratory infections. If the infection is not treated, it can cause serious complications. Ear infections, toxic shock syndrome and kidney inflammation are complications that can occur
Researchers at Lund University studied the blood of patients who had recovered from a severe strep A infection to determine how their immune systems fought the bacteria.
They mapped the antibodies their bodies produced when they were sick from Streptococcus A.
This allowed them to spot those that could be exploited for drugs or vaccines after the infection had occurred.
Researchers using this method have so far failed to develop antibody-based treatments that work against strep A, according to the team.
However, the Swedish group found an antibody that works in a ‘rare’ way against Streptococcus A that has ‘never been described before’ and ‘could explain why so many vaccine attempts have failed’.
Antibodies are shaped like the letter Y. The one they spotted, called Ab25, used its two ‘arms’ to attach to two different parts of a protein on the surface of the Strep A bacteria – called the M protein.
Where this unique process was observed, the body was able to mount a strong response to the bacteria.
Normally, antibodies use one arm to bind to one site, the researchers said. But this procedure is ineffective against Streptococcus A.
dr. Wael Bahnan, an immunologist at Lund and one of the authors of the study, said: ‘This opens up possibilities where previous vaccine attempts have failed and means that the monoclonal antibody we used has the potential to protect against infection.’
The team carried out further tests of the antibody in animals and found that it could produce a ‘strong immune response against the bacteria’.
They have now applied for a patent based on their findings published in the journal EMBO molecular medicineand it is hoped that the antibody will eventually lead to treatment and a vaccine against strep A.
Study author Professor Pontus Nordenfelt said: ‘Normally, an antibody binds via one of its two Y arms to a target protein at one site, regardless of which of the two arms is used for binding.


Although the vast majority of infections are relatively mild, in extremely rare cases the bacteria can cause invasive group A streptococci (iGAS).

Strep A bacteria can cause a number of other infections, including impetigo, scarlet fever and strep throat
‘But what we saw – and this is vital information – is that the two Y arms can recognize and attach to two different sites on the same target protein.’
It came after the UK’s Health Safety Agency confirmed last week that five more children had died from Streptococcus A – bringing the total since September to 24.
The vast majority occurred in England (21), followed by Wales (2) and Northern Ireland (1).
Although low, the number of children in Britain who have died from strep A is higher than expected for this time of year.
Twenty-seven under-18s died from the bug in the entire last worst season, 2017/18.
Strep A bacteria can cause a number of infections. Although the vast majority are relatively mild, in extremely rare cases the bacteria can cause invasive group A streptococci (iGAS).
Two of the most severe forms of this invasive disease are necrotizing fasciitis and streptococcal toxic shock syndrome. Both can kill.
Data suggests that cases of iGAS are already up to five times higher than last winter — which was unusually quiet.
An increase in iGAS cases usually occurs every three to four years, but social distancing during the Covid pandemic is thought to have broken this cycle.
Some experts have suggested that this has reduced immunity to strep A in some children – with a large number of children never having encountered the bacteria in their lives.
High rates of other respiratory viruses — including influenza, RSV and norovirus — may also put children at greater risk of co-infection with Streptococcus A, making them more susceptible to severe illness, the World Health Organization said.
Last week, experts revealed that five times as many penicillin prescriptions were issued compared to the previous three weeks.
They said some forms of antibiotics could be put on a ‘shortage protocol’ to allow pharmacists to give worried parents alternatives, rather than forcing them to wander around different pharmacies or go back to their GP for a new prescription.
In other health related news…
NHS treatment goals are be ditched in reforms designed to free trusts from ‘bureaucratic burdens’
One in FOUR older Britons the fear of having to resort to DIY dentistry because a top dentist is attacking a ‘broken’ system
Forgetting gifts, not turning on the oven and getting lost in a relative’s house: Signs a loved one could have dementia this Christmas
#vaccine #strep #horizon #scientists #spotted #antibodies #fight #infection